OncoSynergy
Stamford
About OncoSynergy
The vision of OncoSynergy, a UCSF spin-out, is to radically improve outcomes for patients with unmet needs in oncology with Resistance Mechanism Inhibitors (RMIs). This new class of therapeutics simultaneously targets multiple hallmarks of cancer progression and have demonstrated dramatic preclinical efficacy as monotherapy and in strategic combinations. It was founded in 2011 and is headquartered in Greenwich, Connecticut.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $23.3M
- Funding stage: M&A
- Last round: Series Unknown (Sep 2020)
- Website: oncosynergy.com
- Phone: 415-299-4249
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oncosynergy-130248 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.